{"id":376,"date":"2022-04-01T16:33:23","date_gmt":"2022-04-01T16:33:23","guid":{"rendered":"https:\/\/kidneydiseaseclinic.net\/blog\/?p=376"},"modified":"2022-04-16T16:01:55","modified_gmt":"2022-04-16T16:01:55","slug":"common-drugs-used-in-cpr","status":"publish","type":"post","link":"https:\/\/kidneydiseaseclinic.net\/blog\/common-drugs-used-in-cpr\/","title":{"rendered":"Common Drugs Used In CPR"},"content":{"rendered":"\n<figure class=\"wp-block-table is-style-stripes\"><table><tbody><tr><td>DRUG<\/td><td>MAIN ACLS USE<\/td><td>DOSE\/ROUTE<\/td><td>NOTES<\/td><\/tr><tr><td>Adenosine<\/td><td>Narrow PSVT\/SVTWide QRS tachy &#8211; avoid adenosine in irregular wide QRS<\/td><td>6 mg IV bolus, may repeat with 12 mg in 1 to 2 min.<\/td><td>Rapid IV push close to the hub, followed by a saline bolusContinuous cardiac monitoring during administrationCauses flushing and chest heaviness<\/td><\/tr><tr><td>Amiodarone<\/td><td>VF\/pulseless VTVT with pulseTachy rate control<\/td><td>VF\/VT:300 mg dilute in 20 to 30 mLmay repeat 150 mg in 3 to 5 min<\/td><td>Anticipate hypotension, bradycardia<br>and gastrointestinal toxicity<br>Continuous cardiac monitoring<br>Very long half life (up to 40 days)<br>Do not use in 2nd or 3rd degree heart block<br>Do not administer via the ET tube route<\/td><\/tr><tr><td>Atropine<\/td><td>Symptomatic bradycardia<\/td><td>0.5 mg IV\/ET every 3 to 5 minutesMax dose: 3 mg<\/td><td>Cardiac and BP monitoringDo not use in glaucoma<br>or tachyarrhythmias<br>Minimum dose 0.5 mg<\/td><\/tr><tr><td>Dopamine<\/td><td>Shock\/CHF<\/td><td>2 to 20 mcg\/kg\/ min<br>Titrate to desired blood pressure<\/td><td>Fluid resuscitation first<br>Cardiac and BP monitoring<\/td><\/tr><tr><td>Epinephrine<\/td><td>Cardiac Arrest<\/td><td>Initial: 1.0 mg (1:10000)IV or 2 to 2.5 mg (1:1000)ETT every 3 to 5 min<br>Maintain: 0.1 to 0.5 mcg\/kg\/minTitrate to desire blood pressure<\/td><td>Continuous cardiac monitoring<br>Note: Distinguish between 1:1000 and 1:10000 concentrations<br>Give via central line when possible<\/td><\/tr><tr><td>Lidocaine (Lidocaine is recommended<br>when Amiodarone is not available)<\/td><td>Cardiac Arrest (VF\/VT)<\/td><td>Initial: 1 to 1.5 mg\/kg IV loading<br>Second: Half of first dose in 5 to 10 minMaintain: 1 to 4 mg\/min<\/td><td>Cardiac and BP monitoringRapid bolus can cause hypotension and bradycardiaUse with caution in renal failure<br>Calcium chloride can<br>reverse hypermagnesemia<\/td><\/tr><tr><td>Magnesium Sulfate<\/td><td>Cardiac arrest\/ Pulseless torsades<\/td><td>Cardiac Arrest: 1 to 2 gm diluted in 10 mL D5W IVP<\/td><td>Cardiac and BP monitoring<br>Rapid bolus can cause<br>hypotension and bradycardia<br>Use with caution in renal failureCalcium chloride can reverse hypermagnesemia<\/td><\/tr><tr><td>Procainamide<\/td><td>Wide QRS tachycardia<br>Preferred for VT with pulse (stable)<\/td><td>20 to 50 mg\/min IV until rhythm improves hypotension occurs, QRS widens by 50% or MAX dose is given  MAX dose: 17 mg\/kg<br>Drip: 1 to 2 gm in 250 to 500 mL at 1 to 4 mg\/min<\/td><td>Cardiac and BP monitoringCaution with acute MI<br>May reduce dose with renal failure<br>Do not give with amiodarone<br>Do not use in prolonged QT or CHF<\/td><\/tr><tr><td>Sotalol<\/td><td>Tachyarrhythmia<br>Monomorphic VT3rd line anti-arrhythmic<\/td><td>100 mg (1.5 mg\/kg) IV over 5 min<\/td><td>Do not use in prolonged QT<\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"<p>DRUG MAIN ACLS USE DOSE\/ROUTE NOTES Adenosine Narrow PSVT\/SVTWide QRS tachy &#8211; avoid adenosine in irregular wide QRS 6 mg IV bolus, may repeat with 12 mg in 1 to 2 min. Rapid IV push close to the hub, followed by a saline bolusContinuous cardiac monitoring during administrationCauses flushing and chest heaviness Amiodarone VF\/pulseless VTVT [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[1],"tags":[],"class_list":["post-376","post","type-post","status-publish","format-standard","hentry","category-med"],"_links":{"self":[{"href":"https:\/\/kidneydiseaseclinic.net\/blog\/wp-json\/wp\/v2\/posts\/376","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/kidneydiseaseclinic.net\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/kidneydiseaseclinic.net\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/blog\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/blog\/wp-json\/wp\/v2\/comments?post=376"}],"version-history":[{"count":4,"href":"https:\/\/kidneydiseaseclinic.net\/blog\/wp-json\/wp\/v2\/posts\/376\/revisions"}],"predecessor-version":[{"id":683,"href":"https:\/\/kidneydiseaseclinic.net\/blog\/wp-json\/wp\/v2\/posts\/376\/revisions\/683"}],"wp:attachment":[{"href":"https:\/\/kidneydiseaseclinic.net\/blog\/wp-json\/wp\/v2\/media?parent=376"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/blog\/wp-json\/wp\/v2\/categories?post=376"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/kidneydiseaseclinic.net\/blog\/wp-json\/wp\/v2\/tags?post=376"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}